Professional Overview

Nicholas Sarlis is a seasoned medical executive currently serving as the Chief Medical Officer at CLEARA Biotech BV, where he spearheads clinical development, translational science, and medical affairs in oncology projects. His expertise spans clinical development, medical affairs, and translational science, with a strong focus on the oncology sector.

Experience Summary

Current Role

As the Chief Medical Officer at CLEARA Biotech BV, Nicholas leads the development and implementation of clinical strategies, oversees translational science initiatives, and directs medical affairs in oncology. His current role involves collaborations with cross-functional teams to advance oncology projects, ensuring alignment with regulatory requirements and industry standards.

Career Progression

Nicholas has progressed through various leadership roles, including Chief Medical Officer positions at The Lynx Group and Sellas Life Sciences, as well as Vice President and Head of Global Medical Affairs at Incyte Corporation. His career trajectory reflects growth in responsibilities, from senior clinical investigator roles at the National Institutes of Health to executive positions in the biotech industry.

Career Highlights

• Chief Medical Officer at CLEARA Biotech BV (2023-Present)

• Head of Medical Content at Amplity Health (2022-2023)

• Chief Medical Officer at The Lynx Group (2021-2022)

• Executive Medical Advisor at The Lynx Group (2019-2021)

• Senior Advisory Consultant at Sellas Life Sciences (2020-2021)

• Chief Medical Officer at Sellas Life Sciences (2019-2020, 2016-2019)

• Vice President; Head, Global Medical Affairs at Incyte Corporation (2015-2016)

• Vice President; Head, Medical Affairs at Incyte Corporation (2010-2015)

Areas of Expertise

Nicholas possesses deep expertise in oncology, clinical development, translational science, and medical affairs. His technical competencies include strategy development, team leadership, and collaboration with cross-functional teams. As a seasoned executive, he demonstrates strong leadership and management capabilities, with a proven track record of driving projects forward and achieving industry impact.

Professional Impact

Throughout his career, Nicholas has contributed to numerous initiatives and projects, driving growth and advancement in the oncology sector. While specific metrics are not available, his leadership roles and responsibilities reflect a high level of industry impact and influence.

Conclusion

Nicholas Sarlis is a highly experienced medical executive with a strong background in oncology, clinical development, and medical affairs. Currently, as the Chief Medical Officer at CLEARA Biotech BV, he continues to drive innovation and advancement in the oncology sector. With his extensive expertise, leadership capabilities, and industry focus, Nicholas is well-positioned to make significant contributions to the development of oncology treatments and therapies.